Continuing Education

Defining a Clinically Important Change in 6-Minute Walk Distance in Patients With Heart Failure and Mitral Valve Disease

March 5, 2021 Editor

Circulation: Heart Failure, Ahead of Print.

← In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure
Ventricular Systolic Discordance Post-Premature Ventricular Complex in Constrictive Pericarditis →